


A Young Disease: A Holistic Approach to the Treatment of Antiphospholipid Syndrome

Clinical Challenges in SLE: Glucocorticoids—How Much Is Too Much?

Improving Bone Mineral Density: Risedronate vs. Denosumab

How Do Reduced-Dose Glucocorticoids Plus Rituximab Affect ANCA-Associated Vasculitis?

FDA’s Arthritis Advisory Committee Narrowly Endorses Avacopan Approval

Efficacy of Tocilizumab Monotherapy After Ultra-Short Glucocorticoid Administration in GCA

Study: Can Avacopan Replace Steroids in ANCA-Associated Vasculitis?

Denosumab Has Edge on Alendronate for Steroid-Induced Bone Loss

A Year to Remember: Dr. Jinoos Yazdany Presents the 2020 Clinical Research Review
- 1
- 2
- 3
- 4
- Next Page »